PF-01913539

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-01913539, covering 2010-06-29 to 2010-06-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease [Phase 2]